Drugs / ARLIPOIC ACID CHOLINE ESTER
ARLIPOIC ACID CHOLINE ESTER
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02516306 | Sep 2015 → Mar 2016 | presbyopia | Encore Vision, Inc. | Completed | No outcome recorded |
| Phase 21 trial · 1 missed | ||||||
| Phase 2 | NCT04806503 | Jun 2021 → Jul 2022 | presbyopia | Novartis Pharmaceuticals | Terminated | Missed primary |
Evidence & citations 13 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ARLIPOIC ACID CHOLINE ESTER | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650743 ↗ |
| Known as | .alpha.-r-lipoic acid choline ester chloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650743 ↗ |
| Known as | ARLIPOIC ACID CHOLINE ESTER CHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650743 ↗ |
| Known as | Choline lipoate chloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650743 ↗ |
| Known as | EV-06 CHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650743 ↗ |
| Known as | EV06 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02516306 ↗ |
| Known as | Lace chloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650743 ↗ |
| Known as | UMR-844 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650743 ↗ |
| Known as | UMR-844 CHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650743 ↗ |
| Known as | UNR844 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04806503 ↗ |
| Known as | UNR844 CHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650743 ↗ |
| Modality | Small molecule | — CHEMBL4650743 ↗ |
| Route | Topical | “subjects applied 1 drop of their assigned study product to one eye twice per day.” NCT02516306 ↗ |